INS and Obesity: In addition, the prevalence of autoantibodies in overweight and obese adolescent patients was similar to that in nonobese healthy adolescents (2.18% and 1.86%), suggesting that obesity and insulin resistance do not increase the prevalence of insulin autoantibodies and the progression of islet autoimmune destruction [15].